Welcome to our dedicated page for ONEM news (Ticker: ONEM), a resource for investors and traders seeking the latest updates and insights on ONEM stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ONEM's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ONEM's position in the market.
One Medical (Nasdaq: ONEM) announced significant findings from a peer-reviewed longitudinal study published in JMIR Diabetes. The study examined a cohort of 621 patients with uncontrolled diabetes, revealing a 19% decrease in average HbA1c levels, from 10.7% to 8.7%. This improvement is notably higher compared to virtual-only solutions, which showed modest gains. The company’s integrated diabetes management program emphasizes 24/7 access to care, self-management tools, and a proprietary technology platform designed to enhance chronic disease management.
1Life Healthcare, Inc. (One Medical) reported a strong Q1 2021, with membership reaching 598,000, reflecting a 31% year-over-year rise. The company generated net revenue of $121.4 million, a 54% increase from the previous year. The cash and short-term marketable securities stood at $703.6 million. CEO Amir Dan Rubin highlighted continued growth through technology and new market expansions, including a partnership with Baylor Scott & White to enter the Dallas-Fort Worth area. However, the company reported a net loss of $39.3 million, or 32% of revenue.
One Medical is set to launch its technology-driven primary care model in the Dallas-Fort Worth area through a collaboration with Baylor Scott & White Health, Texas's largest not-for-profit health system. This partnership will offer coordinated care combining One Medical’s membership-based approach with Baylor's extensive healthcare network. The aim is to enhance patient experience via 24/7 telehealth access and in-person services. This marks One Medical's entry into its 19th market and aligns with its mission to transform healthcare.
One Medical is expanding its technology-powered primary care model to Florida through a partnership with the University of Miami Health System. This collaboration aims to enhance coordinated care for South Florida residents, combining One Medical's membership-based approach with UHealth's extensive healthcare network. One Medical plans to enter the Miami-Dade region as its 18th market, offering 24/7 telehealth services, improving clinical integration, and providing value to consumers and employers. The initiative aligns with One Medical's mission to transform healthcare delivery in Florida.
1Life Healthcare (One Medical) will release its first quarter 2021 financial results on May 12, 2021, after market close. A conference call is scheduled for the same day at 1:30 p.m. PT/4:30 p.m. ET to discuss the results. Investors can participate via a live audio webcast or by phone. One Medical focuses on a membership-based, technology-driven primary care model aimed at enhancing user experience and reducing healthcare costs.
1Life Healthcare, Inc. (One Medical) reported its financial results for Q4 and FY 2020, highlighting a significant membership growth and revenue increase. The membership count reached 549,000, up 30% year-over-year. Q4 net revenue was $121.8 million, reflecting a 57% increase, while FY 2020 net revenue reached $380.2 million, a 38% rise. Despite these gains, the company reported a net loss of $8.1 million in Q4 and $89.4 million for the full year. Ending cash and short-term investments stood at $683.0 million.
1Life Healthcare, Inc. (One Medical) (Nasdaq: ONEM) is set to release its fourth quarter and full fiscal year 2020 results on February 25, 2021, after market close. A conference call will follow at 1:30 p.m. PT / 4:30 p.m. ET to discuss these financial results. Investors can access a live audio webcast on their investor relations website. One Medical operates a membership-based, technology-powered primary care platform, focusing on enhancing care and reducing costs.
One Medical (NASDAQ: ONEM) expands its COVID-19 vaccination efforts in key U.S. cities including New York, Los Angeles, Seattle, and the San Francisco Bay Area. The organization is now administering vaccines to Phase 1a and select Phase 1b populations, following guidelines from health authorities. One Medical is utilizing its technology platform for scheduling and follow-up services while collaborating with local health departments. This initiative aims to improve community health through efficient vaccine delivery and access to telehealth services.
1Life Healthcare, Inc. (One Medical) announced that its CEO Amir Dan Rubin and CFO Bjorn Thaler will attend the 39th Annual J.P. Morgan Healthcare Conference. The presentation and fireside chat is scheduled for January 12th, 2021, at 8:40 a.m. PT / 11:40 a.m. ET. A live audio webcast and a replay of the event will be accessible via One Medical's investor page.
One Medical focuses on a membership-based, technology-driven primary care model, aiming to enhance member experience while reducing healthcare costs.
FAQ
What is the market cap of ONEM (ONEM)?
